Treatment of hemophilia is evolving. The individualized care approach is being increasingly recognized for its advantages such as improved long‐term outcomes and quality of life and reduced direct and indirect treatment costs. 1 Although hemophilia always had a multidisciplinary and personalization intent, an individualized approach based on pharmacokinetics has recently begun to implement. 2 To throw more light onto the subject,   Takeda  and  Docplexus  have organized a webinar on 5 th August  2020 , Wednesday from 7:30 PM .

In this webinar,  Dr. Jan Blatny will be sharing his expertise on the topic “Optimizing Hemophilia Treatment With Personalisation.”              We invite you to submit your queries, which will be addressed by the speaker at the end of the session. References Jackson S, Santoro C, Gue D, Ferretti A, Gaglioti D, Squire S, Mazzucconi MG, Hermans C. Clinical…